Elysium Health™ Raises $20 Million In Series B Financing Led By General Catalyst, Announces Topline Clinical Trial Results For Its First Product BASIS™, And Welcomes Leading Scientists And Physicians To Its Scientific Advisory Board
Home » Elysium Health™ Raises $20 Million In Series B Financing Led By General Catalyst, Announces Topline Clinical Trial Results For Its First Product BASIS™, And Welcomes Leading Scientists And Physicians To Its Scientific Advisory Board
Elysium Health™ Raises $20 Million In Series B Financing Led By General Catalyst, Announces Topline Clinical Trial Results For Its First Product BASIS™, And Welcomes Leading Scientists And Physicians To Its Scientific Advisory Board2016-12-062016-12-08http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.